Auteurs
Analysis
Allemagne
Racine
Analysis
Allemagne
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur les relations entre la France et l'Australie - Analysis (Allemagne)

Index « Auteurs » - entrée « Jean Jacques Grob »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Jean Jacques De Bruycker < Jean Jacques Grob < Jean Jacques Martin  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 5.
Ident.Authors (with country if any)Title
000105 (2017) Selma Ugurel [Allemagne] ; Joachim Röhmel [Allemagne] ; Paolo A. Ascierto [Italie] ; Keith T. Flaherty [États-Unis] ; Jean Jacques Grob [France] ; Axel Hauschild [Allemagne] ; James Larkin [Royaume-Uni] ; Georgina V. Long [Australie] ; Paul Lorigan [Royaume-Uni] ; Grant A. Mcarthur [Australie] ; Antoni Ribas [États-Unis] ; Caroline Robert [France] ; Dirk Schadendorf [Allemagne] ; Claus Garbe [Allemagne]Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017.
000662 (2016) Selma Ugurel [Allemagne] ; Joachim Röhmel [Allemagne] ; Paolo A. Ascierto [Italie] ; Keith T. Flaherty [États-Unis] ; Jean Jacques Grob [France] ; Axel Hauschild [Allemagne] ; James Larkin [Royaume-Uni] ; Georgina V. Long [Australie] ; Paul Lorigan [Royaume-Uni] ; Grant A. Mcarthur [Australie] ; Antoni Ribas [États-Unis] ; Caroline Robert [France] ; Dirk Schadendorf [Allemagne] ; Claus Garbe [Allemagne]Survival of patients with advanced metastatic melanoma: The impact of novel therapies.
000D46 (2015) Jean Jacques Grob [France] ; Georgina V. Long [Australie] ; Dirk Schadendorf [Allemagne] ; Keith Flaherty [États-Unis]Disease kinetics for decision-making in advanced melanoma: a call for scenario-driven strategy trials.
000D76 (2015) Jean Jacques Grob [France] ; Mayur M. Amonkar [États-Unis] ; Boguslawa Karaszewska [Pologne] ; Jacob Schachter [Israël] ; Reinhard Dummer [Suisse] ; Andrzej Mackiewicz [Pologne] ; Daniil Stroyakovskiy [Russie] ; Kamil Drucis [Pologne] ; Florent Grange [France] ; Vanna Chiarion-Sileni [Italie] ; Piotr Rutkowski [Pologne] ; Mikhail Lichinitser [Russie] ; Evgeny Levchenko [Russie] ; Pascal Wolter [Belgique] ; Axel Hauschild [Allemagne] ; Georgina V. Long [Australie] ; Paul Nathan [Royaume-Uni] ; Antoni Ribas [États-Unis] ; Keith Flaherty [États-Unis] ; Peng Sun [États-Unis] ; Jeffrey J. Legos [États-Unis] ; Diane Opatt Mcdowell [États-Unis] ; Bijoyesh Mookerjee [États-Unis] ; Dirk Schadendorf [Allemagne] ; Caroline Robert [France]Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial.
001520 (2013) Steven J. O'Day [États-Unis] ; Alexander M. M. Eggermont [France] ; Vanna Chiarion-Sileni [Italie] ; Richard Kefford [Australie] ; Jean Jacques Grob [France] ; Laurent Mortier [France] ; Caroline Robert [France] ; Jacob Schachter [Israël] ; Alessandro Testori [Italie] ; Jacek Mackiewicz [Pologne] ; Philip Friedlander [États-Unis] ; Claus Garbe [Allemagne] ; Selma Ugurel [Autriche] ; Frances Collichio [États-Unis] ; WEI GUO [États-Unis] ; Joelle Lufkin [États-Unis] ; Safi Bahcall [États-Unis] ; Vojo Vukovic [États-Unis] ; Axel Hauschild [Allemagne]Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma

List of associated KwdEn.i

Nombre de
documents		Descripteur
4Humans
4Melanoma (drug therapy)
4Melanoma (secondary)
4Skin Neoplasms (drug therapy)
4Skin Neoplasms (pathology)
3Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
3Melanoma (mortality)
3Protein Kinase Inhibitors (therapeutic use)
3Skin Neoplasms (mortality)
2Antibodies, Monoclonal (therapeutic use)
2Antineoplastic Agents (therapeutic use)
2Antineoplastic Combined Chemotherapy Protocols (adverse effects)
2Clinical Trials as Topic
2Disease Progression
2Kaplan-Meier Estimate
2Risk Factors
1Administration, Oral
1Advanced stage
1Algorithms
1Antineoplastic Combined Chemotherapy Protocols (administration & dosage)
1Antineoplastic agent
1Biomarkers, Tumor (genetics)
1Cancerology
1Chemotherapy
1Clinical Trials as Topic (methods)
1Clinical trial
1Comparative study
1Critical Pathways
1DNA Mutational Analysis
1Decision Support Techniques
1Disease-Free Survival
1Double blind study
1Drug Administration Schedule
1Drug Therapy, Combination
1Drugs, Investigational (therapeutic use)
1Elesclomol
1Genetic Predisposition to Disease
1Human
1Imidazoles (administration & dosage)
1Imidazoles (adverse effects)
1Imidazoles (therapeutic use)
1Immunotherapy (methods)
1Indoles (administration & dosage)
1Indoles (adverse effects)
1Indoles (therapeutic use)
1Intention to Treat Analysis
1Kinetics
1MAP Kinase Kinase Kinases (antagonists & inhibitors)
1MAP Kinase Kinase Kinases (metabolism)
1Malignant melanoma
1Melanoma (genetics)
1Molecular Targeted Therapy (methods)
1Molecular Targeted Therapy (mortality)
1Mutation
1Neoplasm Metastasis
1Oximes (administration & dosage)
1Oximes (adverse effects)
1Oximes (therapeutic use)
1Paclitaxel
1Patient
1Phase III trial
1Phenotype
1Predictive Value of Tests
1Prognosis
1Prospective Studies
1Protein Kinase Inhibitors (administration & dosage)
1Protein Kinase Inhibitors (adverse effects)
1Proto-Oncogene Proteins B-raf (antagonists & inhibitors)
1Proto-Oncogene Proteins B-raf (genetics)
1Pyridones (administration & dosage)
1Pyridones (adverse effects)
1Pyridones (therapeutic use)
1Pyrimidinones (administration & dosage)
1Pyrimidinones (adverse effects)
1Pyrimidinones (therapeutic use)
1Quality of Life
1Randomization
1Research Design
1Result
1Risk Assessment
1Skin Neoplasms (genetics)
1Sulfonamides (administration & dosage)
1Sulfonamides (adverse effects)
1Sulfonamides (therapeutic use)
1Surveys and Questionnaires
1Therapies, Investigational (mortality)
1Time Factors
1Treatment
1Treatment Outcome

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Allemagne/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i -k "Jean Jacques Grob" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i  \
                -Sk "Jean Jacques Grob" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Allemagne/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Allemagne
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Jean Jacques Grob
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024